glycopeptide,neutral_mass,mass_accuracy,ms1_score,ms2_score,q_value,total_signal,start_time,end_time,apex_time,charge_states,msms_count,peptide_start,peptide_end,protein_name,mass_shifts
QLINALQIN(N-Glycosylation)NTAVGHALVLPAGR{Fuc:2; Hex:6; HexNAc:4},4459.11789101,-4.05491415862e-06,0,63.5465898995,0,0,,,,4,2,2549,2572,sp|P12111|CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens OX=9606 GN=COL6A3 PE=1 SV=5,
QLINALQIN(N-Glycosylation)NTAVGHALVLPAGR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},4442.088464859036,-8.939257711215519e-07,13.8343136026,58.1036254143,0,627466087,84.0743470774,84.340795309,84.200649442895,3;4,2,2549,2572,sp|P12111|CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens OX=9606 GN=COL6A3 PE=1 SV=5,Unmodified
QLINALQIN(N-Glycosylation)NTAVGHALVLPAGR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},4733.220512147674,-8.578024078935836e-06,13.8829822749,46.8281260586,0,540298392.0,88.180911178,88.5762618449,88.355491060638,3;4,2,2549,2572,sp|P12111|CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens OX=9606 GN=COL6A3 PE=1 SV=5,Unmodified
QLINALQIN(N-Glycosylation)NTAVGHALVLPAGR{Fuc:3; Hex:5; HexNAc:4},4443.10676258232,-4.2032058425747223e-07,-20.8970693056,42.5260527503,0,10635576,84.0901274429,84.0901274429,84.0901274429,4,1,2549,2572,sp|P12111|CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens OX=9606 GN=COL6A3 PE=1 SV=5,Unmodified
QLINALQIN(N-Glycosylation)NTAVGHALVLPAGR{Fuc:1; Hex:4; HexNAc:5},4192.03610203,-4.88437431647e-06,0,37.0200077981,0,0,,,,3,1,2549,2572,sp|P12111|CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens OX=9606 GN=COL6A3 PE=1 SV=5,
QLINALQIN(N-Glycosylation)NTAVGHALVLPAGR{Fuc:1; Hex:5; HexNAc:4},4151.024786843836,-8.60254767450012e-06,12.6177694163,29.7988105584,0,113705414.5,80.9483425604,81.0868926432,81.025877959156,3;4,1,2549,2572,sp|P12111|CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens OX=9606 GN=COL6A3 PE=1 SV=5,Unmodified
QLINALQIN(N-Glycosylation)NTAVGHALVLPAGR{Hex:5; HexNAc:4},4004.9683160404766,-9.275325364788944e-06,-3.85903507739,15.3928138622,0,23419565.25,81.2270154105,81.3049334115,81.273802926763,3,1,2549,2572,sp|P12111|CO6A3_HUMAN Collagen alpha-3(VI) chain OS=Homo sapiens OX=9606 GN=COL6A3 PE=1 SV=5,Unmodified
LDAPTNLQFVN(N-Glycosylation)ETDSTVLVR{Fuc:1; Hex:5; HexNAc:4},3999.808967253369,-6.519068086239068e-06,11.0559016726,100.390120435,0,73699967.5,74.6439561115,74.8629055248,74.691150576496,3,2,996,1016,sp|P02751|FINC_HUMAN Fibronectin OS=Homo sapiens OX=9606 GN=FN1 PE=1 SV=5,Unmodified
TDDEVVQREEEAIQLDGLN(N-Glycosylation)ASQIR{Hex:5; HexNAc:2},3943.75930723,-1.3477216373e-06,0,24.6001825894,0,0,,,,3,1,43,67,sp|P14625|ENPL_HUMAN Endoplasmin OS=Homo sapiens OX=9606 GN=HSP90B1 PE=1 SV=1,
GTAGNALMDGASQLMGEN(N-Glycosylation)R{Fuc:2; Hex:5; HexNAc:4},3806.5410060775416,2.118402732383915e-06,-6.46799533163,30.678851295,0,33315493,72.7672239091,73.1653628614,72.874158559863,3,1,376,395,sp|P02675|FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens OX=9606 GN=FGB PE=1 SV=2,Unmodified
GTAGNALMDGASQLMGEN(N-Glycosylation)R{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},4097.63936029,1.25098397858e-06,0,27.5363137003,0,0,,,,3,3,376,395,sp|P02675|FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens OX=9606 GN=FGB PE=1 SV=2,
LN(N-Glycosylation)YSLPTGQWVGVQLPR{Hex:5; HexNAc:2},3143.4659340955586,-3.6553772108067352e-06,13.8314368166,136.473839538,0,423841356.5,84.2162302083,84.5615499085,84.340795308971,2;3,1,1016,1033,sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3,Unmodified
N(N-Glycosylation)LTVPGSLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3015.2886261796775,-2.856856177178932e-06,11.9963500145,106.097650392,0,413961931.5,50.8846739596,51.5088494923,51.222864225133,3,2,1118,1127,sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3,Unmodified
N(N-Glycosylation)NTRGPGLKR{Fuc:1; Hex:5; HexNAc:5},3083.349889158773,-3.231001161517793e-06,15.6556901509,88.2577032289,0,580931547.5,32.3190539108,32.571009726,32.444163491948,3;4,4,787,797,sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3,Unmodified
N(N-Glycosylation)TTSYVLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3303.351574496032,-7.0929784141356036e-06,10.2945474428,62.2299636694,0,87132032.5,44.3697802927,44.8465072261,44.369780292734,3,2,1033,1041,sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3,Unmodified
N(N-Glycosylation)NTRGPGLKR{Fuc:1; Hex:6; HexNAc:5},3245.4072523409745,-4.468490283965584e-06,9.5092948178,58.2115444045,0,190822629.5,32.0380171762,32.4025818771,32.065799894555,3;4,2,787,797,sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3,Unmodified
N(N-Glycosylation)TTSYVLR{Fuc:1; Hex:5; HexNAc:4},2721.145736571465,-3.0963757920377217e-06,12.4031657614,51.8209659356,0,249105542.25,34.5465126938,34.859498877,34.644754225636,2;3,2,1033,1041,sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3,Unmodified
VEAAQN(N-Glycosylation)LTLPGSLR{Fuc:3; Hex:5; HexNAc:4; Neu5Ac:1},3819.66937291,-3.6865071019e-06,0,28.620301679,0,0,,,,3,1,1386,1400,sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3,
VEAAQN(N-Glycosylation)LTLPGSLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3818.66045401,-6.69434478105e-06,0,25.7346139699,0,0,,,,3,1,1386,1400,sp|P24821|TENA_HUMAN Tenascin OS=Homo sapiens OX=9606 GN=TNC PE=1 SV=3,
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:3; HexNAc:4},2633.0448326226356,-2.36711606212441e-06,17.8429320566,130.738793675,0,2774433166.5,27.2005604095,27.6428036597,27.327521159871,2;3,4,175,184,sp|P01857|IGHG1_HUMAN Immunoglobulin heavy constant gamma 1 OS=Homo sapiens OX=9606 GN=IGHG1 PE=1 SV=2,Unmodified
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:5; HexNAc:4},2957.152852545402,-2.910166944772088e-06,17.6359856932,102.128235096,0,620027772.0,27.0625858929,27.3275211599,27.145215494061,2;3,2,175,184,sp|P01857|IGHG1_HUMAN Immunoglobulin heavy constant gamma 1 OS=Homo sapiens OX=9606 GN=IGHG1 PE=1 SV=2,Unmodified
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:4; HexNAc:4},2795.0991819932983,-2.7758137986616785e-06,16.6242080198,100.785200419,0,2304953780.5,27.0902537451,27.5345410413,27.228093741957,2;3,4,175,184,sp|P01857|IGHG1_HUMAN Immunoglobulin heavy constant gamma 1 OS=Homo sapiens OX=9606 GN=IGHG1 PE=1 SV=2,Unmodified
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:3; HexNAc:5},2836.1221598781526,-1.4764733275571773e-06,14.0154136413,91.065497289,0,604357901.5,27.3833341942,27.6968841102,27.47917839152,2;3,3,175,184,sp|P01857|IGHG1_HUMAN Immunoglobulin heavy constant gamma 1 OS=Homo sapiens OX=9606 GN=IGHG1 PE=1 SV=2,Unmodified
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:4; HexNAc:5},2998.1769910500425,-2.0663263479047786e-06,14.870988584,77.7783319034,0,289098355.5,27.2992099113,27.5616570777,27.383334194247,3,2,175,184,sp|P01857|IGHG1_HUMAN Immunoglobulin heavy constant gamma 1 OS=Homo sapiens OX=9606 GN=IGHG1 PE=1 SV=2,Unmodified
GSLSYLN(N-Glycosylation)VTR{Hex:5; HexNAc:2},2325.0256128954975,-6.485183704672208e-06,16.1465507868,145.071386535,0,1526565456.0,51.2673475609,51.7928145594,51.479316261037,2;3,2,256,266,sp|P07339|CATD_HUMAN Cathepsin D OS=Homo sapiens OX=9606 GN=CTSD PE=1 SV=1,Unmodified
GSLSYLN(N-Glycosylation)VTR{Hex:6; HexNAc:2},2487.067652703645,-1.7267756508566717e-06,15.5430423681,134.462197516,0,1269086495.0,51.0000905937,51.4329304761,51.132317493979,2;3,1,256,266,sp|P07339|CATD_HUMAN Cathepsin D OS=Homo sapiens OX=9606 GN=CTSD PE=1 SV=1,Unmodified
GSLSYLN(N-Glycosylation)VTR{Hex:4; HexNAc:2},2162.970782369425,-6.0431286226475724e-06,12.8858825652,108.434588489,0,190375848.0,51.6712408608,52.0021840598,51.942275761191,2,1,256,266,sp|P07339|CATD_HUMAN Cathepsin D OS=Homo sapiens OX=9606 GN=CTSD PE=1 SV=1,Unmodified
GSLSYLN(N-Glycosylation)VTR{Hex:7; HexNAc:2},2649.1230408448764,-2.5892835063471713e-06,14.7766325738,85.3838100289,0,717187879.0,50.7636106756,51.0872694916,50.9712085591,2;3,1,256,266,sp|P07339|CATD_HUMAN Cathepsin D OS=Homo sapiens OX=9606 GN=CTSD PE=1 SV=1,Unmodified
LKISYKDAIN(N-Glycosylation)R{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3670.6060392086847,-5.3275597724598e-06,-4.07835691144,55.8873603853,0,37921106,48.3049325413,48.3650798267,48.304932541275,3,3,2780,2791,sp|P15924|DESP_HUMAN Desmoplakin OS=Homo sapiens OX=9606 GN=DSP PE=1 SV=3,Unmodified
SLN(N-Glycosylation)ESKIEIER{Hex:3; HexNAc:2},2209.03321057206,-1.0140685596221831e-05,10.9132591625,10.9581965469,0.0284090909091,60342190.5,55.8890707598,56.1162891255,55.963829027239,2,2,1694,1705,sp|P15924|DESP_HUMAN Desmoplakin OS=Homo sapiens OX=9606 GN=DSP PE=1 SV=3,Unmodified
LSLHRPALEDLLLGSEAN(N-Glycosylation)LTC(Carbamidomethyl)TLTGLR{Fuc:1; Hex:5; HexNAc:3; Neu5Ac:1},4819.27654273257,-6.223318696253211e-06,-20.4467000974,33.7039425592,0,75018682,96.1891928778,96.2043415096,96.204341509565,4,1,126,153,sp|P01876|IGHA1_HUMAN Immunoglobulin heavy constant alpha 1 OS=Homo sapiens OX=9606 GN=IGHA1 PE=1 SV=3,Unmodified
VVLHPN(N-Glycosylation)YSQVDIGLIK{Hex:5; HexNAc:4; Neu5Ac:2},3998.7883847881367,-2.994638219014911e-06,14.6226125651,106.192325131,0,1419782549.0,74.893733961,75.5639546579,75.125995741908,3;4,5,235,251,sp|P00738|HPT_HUMAN Haptoglobin OS=Homo sapiens OX=9606 GN=HP PE=1 SV=1,Unmodified
MVSHHN(N-Glycosylation)LTTGATLINEQWLLTTAK{Hex:5; HexNAc:4; Neu5Ac:2},4883.177356982778,-4.074439635031157e-06,8.34521485405,27.0184812347,0,98446498.5,80.7461027768,80.9163231081,80.74610277675,4,1,178,202,sp|P00738|HPT_HUMAN Haptoglobin OS=Homo sapiens OX=9606 GN=HP PE=1 SV=1,Unmodified
IWNN(N-Glycosylation)VTR{Hex:5; HexNAc:2},2117.8927468374204,3.3595620363094045e-06,15.6395708848,86.7956798881,0,274763736.5,29.6507036593,29.9584488418,29.776769910876,2,2,182,189,sp|P26640|SYVC_HUMAN Valine--tRNA ligase OS=Homo sapiens OX=9606 GN=VARS1 PE=1 SV=4,Unmodified
N(N-Glycosylation)MSFVNDLTVTQDGRK{Hex:6; HexNAc:2},3202.394910444223,-1.1125438282768064e-05,12.1112317882,33.4650330436,0,30304913.0,57.3856209105,57.476872411,57.416175443554,3,1,195,211,sp|Q9HDC9|APMAP_HUMAN Adipocyte plasma membrane-associated protein OS=Homo sapiens OX=9606 GN=APMAP PE=1 SV=2,Unmodified
ALPQPQN(N-Glycosylation)VTSLLGC(Carbamidomethyl)TH{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},3940.68181525,-4.23018365148e-06,0,16.6761882528,0,0,,,,3,1,446,462,sp|P02790|HEMO_HUMAN Hemopexin OS=Homo sapiens OX=9606 GN=HPX PE=1 SV=2,
N(N-Glycosylation)GSLFAFR{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},3116.25311842,1.86882004689e-06,0,15.2507929327,0.0189873417722,0,,,,3,1,168,176,sp|P04004|VTNC_HUMAN Vitronectin OS=Homo sapiens OX=9606 GN=VTN PE=1 SV=1,
EEQFN(N-Glycosylation)STFR{Fuc:1; Hex:3; HexNAc:4},2601.059270397844,-4.036715796338909e-06,14.7992019928,127.790918928,0,2203608427.0,38.8929324256,39.3887246436,39.078784591579,2;3,4,171,180,sp|P01859|IGHG2_HUMAN Immunoglobulin heavy constant gamma 2 OS=Homo sapiens OX=9606 GN=IGHG2 PE=1 SV=3,Unmodified
EEQFN(N-Glycosylation)STFR{Fuc:1; Hex:4; HexNAc:4},2763.12067259024,-6.904696971468131e-06,15.7801430853,65.8136633778,0,1584606757.0,38.5272339926,39.1074804094,38.951159459972,2;3,4,171,180,sp|P01859|IGHG2_HUMAN Immunoglobulin heavy constant gamma 2 OS=Homo sapiens OX=9606 GN=IGHG2 PE=1 SV=3,Unmodified
YHYN(N-Glycosylation)GTLLDGTSFDTSYSK{Hex:8; HexNAc:2},3871.59115705,-0.000268622396181,0,29.5903022293,0,0,,,,3,1,178,197,sp|Q96AY3|FKB10_HUMAN Peptidyl-prolyl cis-trans isomerase FKBP10 OS=Homo sapiens OX=9606 GN=FKBP10 PE=1 SV=1,
AHARQC(Carbamidomethyl)LLKN(N-Glycosylation)ISIR{Fuc:1; Hex:5; HexNAc:5; Neu5Ac:2},4232.87714457,-6.16503938316e-06,0,14.3565323443,0,0,,,,4,1,965,979,sp|Q29RF7|PDS5A_HUMAN Sister chromatid cohesion protein PDS5 homolog A OS=Homo sapiens OX=9606 GN=PDS5A PE=1 SV=1,
LLVRWLLGMKNN(N-Glycosylation)QSK{Fuc:1; Hex:5; HexNAc:4},3567.65093677,3.52420460192e-06,0,10.5277682065,0.0331491712707,0,,,,3,1,840,855,sp|Q29RF7|PDS5A_HUMAN Sister chromatid cohesion protein PDS5 homolog A OS=Homo sapiens OX=9606 GN=PDS5A PE=1 SV=1,
N(N-Glycosylation)ITRIK{Fuc:1; Hex:4; HexNAc:3},2146.9767190397183,-1.8753920816548588e-06,10.6110991881,35.5764094091,0,106084347.25,51.6873048769,51.9272436764,51.792814559364,2,1,150,156,sp|P51688|SPHM_HUMAN N-sulphoglucosamine sulphohydrolase OS=Homo sapiens OX=9606 GN=SGSH PE=1 SV=1,Unmodified
TPLTAN(N-Glycosylation)ITK{Fuc:1; Hex:5; HexNAc:5; Neu5Ac:1},3220.3854619421463,-6.726155937733442e-06,14.7616796518,59.72554497,0,443865557.0,40.3529344108,40.7842514263,40.531376428032,3,2,199,208,sp|P01877|IGHA2_HUMAN Immunoglobulin heavy constant alpha 2 OS=Homo sapiens OX=9606 GN=IGHA2 PE=1 SV=5,Unmodified
TPLTAN(N-Glycosylation)ITK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3017.3056886292197,-7.046028335826028e-06,11.410808413,55.2130443568,0,147175190.75,40.4270128276,40.7101267443,40.546224743748,3,2,199,208,sp|P01877|IGHA2_HUMAN Immunoglobulin heavy constant alpha 2 OS=Homo sapiens OX=9606 GN=IGHA2 PE=1 SV=5,Unmodified
LSLHRPALEDLLLGSEAN(N-Glycosylation)LTC(Carbamidomethyl)TLTGLR{Fuc:1; Hex:5; HexNAc:3; Neu5Ac:1},4819.27654273257,-6.223318696253211e-06,-20.4467000974,33.7039425592,0,75018682,96.1891928778,96.2043415096,96.204341509565,4,1,113,140,sp|P01877|IGHA2_HUMAN Immunoglobulin heavy constant alpha 2 OS=Homo sapiens OX=9606 GN=IGHA2 PE=1 SV=5,Unmodified
VIGN(N-Glycosylation)GSFGVVYQAR{Fuc:1; Hex:5; HexNAc:3},3031.3138072,4.65092604285e-06,0,10.7054157248,0.0331491712707,0,,,,3,1,123,137,sp|P49840|GSK3A_HUMAN Glycogen synthase kinase-3 alpha OS=Homo sapiens OX=9606 GN=GSK3A PE=1 SV=2,
GHTLTLN(N-Glycosylation)FTR{Hex:6; HexNAc:3},2740.191787891742,-8.09206945665648e-06,9.64631265044,77.1103962188,0,47040386.0,50.2265385256,50.3320487923,50.257220676168,3,2,96,106,sp|P11279|LAMP1_HUMAN Lysosome-associated membrane glycoprotein 1 OS=Homo sapiens OX=9606 GN=LAMP1 PE=1 SV=3,Unmodified
GHTLTLN(N-Glycosylation)FTR{Hex:6; HexNAc:3; Neu5Ac:1},3031.28280472,-5.86357159498e-06,0,76.4117394037,0,0,,,,3,1,96,106,sp|P11279|LAMP1_HUMAN Lysosome-associated membrane glycoprotein 1 OS=Homo sapiens OX=9606 GN=LAMP1 PE=1 SV=3,
KDN(N-Glycosylation)TTVTR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3284.332476666931,-4.314173465076851e-06,13.7745523,38.4353290481,0,161410366.0625,24.3813139942,25.0682680116,24.562549343332,3,2,246,254,sp|P11279|LAMP1_HUMAN Lysosome-associated membrane glycoprotein 1 OS=Homo sapiens OX=9606 GN=LAMP1 PE=1 SV=3,Unmodified
GHTLTLN(N-Glycosylation)FTR{Fuc:4; Hex:8; HexNAc:8},4663.9174855,-2.94319098751e-06,0,15.1748478664,0,0,,,,3,2,96,106,sp|P11279|LAMP1_HUMAN Lysosome-associated membrane glycoprotein 1 OS=Homo sapiens OX=9606 GN=LAMP1 PE=1 SV=3,
EKSTFIN(N-Glycosylation)M(Oxidation)TR{Fuc:2; Hex:6; HexNAc:4; Neu5Ac:1},3609.46379929,-2.96780970413e-06,0,28.2680547058,0,0,,,,3,1,384,394,sp|P11215|ITAM_HUMAN Integrin alpha-M OS=Homo sapiens OX=9606 GN=ITGAM PE=1 SV=2,
TVIN(N-Glycosylation)FTMPNTIKHYVHRVGR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},4441.992171190575,3.838290390184825e-06,13.8519942182,35.5844966749,0,762499044,80.0480697618,80.3607498433,80.221310308202,3;4,1,533,553,sp|Q96GQ7|DDX27_HUMAN Probable ATP-dependent RNA helicase DDX27 OS=Homo sapiens OX=9606 GN=DDX27 PE=1 SV=2,Unmodified
TKTEISEMNRN(N-Glycosylation)ISR{Hex:5; HexNAc:4; Neu5Ac:2},3882.6375635369104,-4.714820119286431e-06,14.2982751095,33.2300641953,0,1424801099.75,83.8558834261,85.1571234093,84.372411074861,3,4,302,316,"sp|P05787|K2C8_HUMAN Keratin, type II cytoskeletal 8 OS=Homo sapiens OX=9606 GN=KRT8 PE=1 SV=7",Unmodified
TKTEISEMNRN(N-Glycosylation)ISR{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},3883.65170095,-3.10075670993e-06,0,18.4775566144,0,0,,,,3,1,302,316,"sp|P05787|K2C8_HUMAN Keratin, type II cytoskeletal 8 OS=Homo sapiens OX=9606 GN=KRT8 PE=1 SV=7",
TKTEISEMNRN(N-Glycosylation)ISR{Fuc:2; Hex:5; HexNAc:4},3592.55960299,-4.27572740255e-06,0,16.5200801523,0,0,,,,3,1,302,316,"sp|P05787|K2C8_HUMAN Keratin, type II cytoskeletal 8 OS=Homo sapiens OX=9606 GN=KRT8 PE=1 SV=7",
EVN(N-Glycosylation)DTLLVNELK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3445.49527204,-5.84228292922e-06,0,18.9585261078,0,0,,,,3,1,596,608,sp|Q15063|POSTN_HUMAN Periostin OS=Homo sapiens OX=9606 GN=POSTN PE=1 SV=2,
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:3; HexNAc:4},2633.0448326226356,-2.36711606212441e-06,17.8429320566,130.738793675,0,2774433166.5,27.2005604095,27.6428036597,27.327521159871,2;3,4,294,303,sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:5; HexNAc:4},2957.152852545402,-2.910166944772088e-06,17.6359856932,102.128235096,0,620027772.0,27.0625858929,27.3275211599,27.145215494061,2;3,2,294,303,sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:4; HexNAc:4},2795.0991819932983,-2.7758137986616785e-06,16.6242080198,100.785200419,0,2304953780.5,27.0902537451,27.5345410413,27.228093741957,2;3,4,294,303,sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:3; HexNAc:5},2836.1221598781526,-1.4764733275571773e-06,14.0154136413,91.065497289,0,604357901.5,27.3833341942,27.6968841102,27.47917839152,2;3,3,294,303,sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
EEQYN(N-Glycosylation)STYR{Fuc:1; Hex:4; HexNAc:5},2998.1769910500425,-2.0663263479047786e-06,14.870988584,77.7783319034,0,289098355.5,27.2992099113,27.5616570777,27.383334194247,3,2,294,303,sp|P0DOX5|IGG1_HUMAN Immunoglobulin gamma-1 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
LQLSNGN(N-Glycosylation)MTLTLLSVK{Hex:7; HexNAc:2},3271.508892673146,-6.213475944065415e-06,12.7880417195,114.949173502,0,199122865.75,81.8951798942,82.1475207752,82.053273593012,3,2,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)M(Oxidation)TLTLLSVK{Hex:5; HexNAc:2},2963.4002319318656,-7.558390960552315e-06,11.2715429405,82.1987608513,0,105682318.25,74.5351573255,74.7531608925,74.597322975222,2;3,3,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)MTLTLLSVK{Hex:5; HexNAc:2},2947.4085080014206,-8.68207003246335e-06,14.1192815665,48.1814360415,0,291517080.75,82.3199943608,82.6174447761,82.491729643567,2;3,1,190,206,sp|P40199|CEAM6_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 6 OS=Homo sapiens OX=9606 GN=CEACAM6 PE=1 SV=4,Unmodified
M(Oxidation)IEN(N-Glycosylation)GSLSFLPTLR{Fuc:3; Hex:5; HexNAc:4},3653.55522748,6.38690357667e-06,0,76.4516891385,0,0,,,,3,1,266,280,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,
M(Oxidation)IEN(N-Glycosylation)GSLSFLPTLR{Fuc:3; Hex:5; HexNAc:4},3653.598783422383,-5.534553447585771e-06,11.7697001387,72.4673063188,0,350653652.5,84.8905597753,85.2509379771,85.11039309365,3,4,266,280,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,Unmodified
MIEN(N-Glycosylation)GSLSFLPTLR{Fuc:1; Hex:5; HexNAc:4},3345.4956164834284,-8.305704103167229e-06,9.19696297853,63.3397299466,0,95472876.0,80.1432232764,80.3161135421,80.20566029412,3,1,266,280,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,Unmodified
LLQVVYLHSNN(N-Glycosylation)ITK{Fuc:3; Hex:5; HexNAc:4},3701.67519469,1.38584852526e-06,0,58.0617496791,0,0,,,,3,2,300,314,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,
MIEN(N-Glycosylation)GSLSFLPTLR{Fuc:3; Hex:5; HexNAc:4; Neu5Ac:1},3928.69193965,-3.27736528559e-06,0,27.0453741169,0,0,,,,3,1,266,280,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,
MIEN(N-Glycosylation)GSLSFLPTLR{Fuc:3; Hex:5; HexNAc:4},3637.58784112,-1.15288901132e-06,0,22.8134741101,0,0,,,,3,1,266,280,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,
MIEN(N-Glycosylation)GSLSFLPTLR{Hex:7; HexNAc:6},3929.69726899,-5.84170338804e-06,0,13.537642713,0,0,,,,3,1,266,280,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,
MIEN(N-Glycosylation)GSLSFLPTLR{Fuc:1; Hex:6; HexNAc:5; Neu5Ac:1},4001.67076759,6.16608486372e-06,0,13.2351642709,0.0062893081761,0,,,,3,1,266,280,sp|P21810|PGS1_HUMAN Biglycan OS=Homo sapiens OX=9606 GN=BGN PE=1 SV=2,
KKEDALN(N-Glycosylation)ETR{Fuc:2; Hex:8; HexNAc:5; Neu5Ac:1},4097.64015919,3.9143180089e-06,0,21.0584849257,0,0,,,,3,1,79,89,sp|P10909|CLUS_HUMAN Clusterin OS=Homo sapiens OX=9606 GN=CLU PE=1 SV=1,
GVFITN(N-Glycosylation)ETGQPLIGK{Hex:7; HexNAc:2},3113.4009942335706,-6.850331277698204e-06,10.3705596652,124.864100114,0,87718729.5,62.0217516607,62.1109144277,62.096420676136,2;3,2,464,479,sp|P10253|LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens OX=9606 GN=GAA PE=1 SV=4,Unmodified
GVFITN(N-Glycosylation)ETGQPLIGK{Hex:6; HexNAc:2},2951.3387821092524,-4.045324266017449e-06,-5.96285248582,118.191681085,0,18150308.25,62.2781027939,62.4616172618,62.278102793916,3,2,464,479,sp|P10253|LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens OX=9606 GN=GAA PE=1 SV=4,Unmodified
QVVEN(N-Glycosylation)MTR{Hex:5; HexNAc:2},2191.909815303172,-2.823210397908137e-06,14.8073236557,101.433591553,0,194005673.75,29.2062075442,29.4557307587,29.302803741519,2,2,385,393,sp|P10253|LYAG_HUMAN Lysosomal alpha-glucosidase OS=Homo sapiens OX=9606 GN=GAA PE=1 SV=4,Unmodified
DLQNVN(N-Glycosylation)ITLR{Fuc:1; Hex:6; HexNAc:5},3318.422954002559,2.8126737345274564e-08,14.7259275509,68.9999698264,0,185177184.0,26.0305544085,26.1464240259,26.089210059865,3;4,4,83,93,sp|P35232|PHB1_HUMAN Prohibitin 1 OS=Homo sapiens OX=9606 GN=PHB1 PE=1 SV=1,Unmodified
TPLTAN(N-Glycosylation)ITK{Fuc:1; Hex:5; HexNAc:5; Neu5Ac:1},3220.3854619421463,-6.726155937733442e-06,14.7616796518,59.72554497,0,443865557.0,40.3529344108,40.7842514263,40.531376428032,3,2,314,323,sp|P0DOX2|IGA2_HUMAN Immunoglobulin alpha-2 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
TPLTAN(N-Glycosylation)ITK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3017.3056886292197,-7.046028335826028e-06,11.410808413,55.2130443568,0,147175190.75,40.4270128276,40.7101267443,40.546224743748,3,2,314,323,sp|P0DOX2|IGA2_HUMAN Immunoglobulin alpha-2 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
LSLHRPALEDLLLGSEAN(N-Glycosylation)LTC(Carbamidomethyl)TLTGLR{Fuc:1; Hex:5; HexNAc:3; Neu5Ac:1},4819.27654273257,-6.223318696253211e-06,-20.4467000974,33.7039425592,0,75018682,96.1891928778,96.2043415096,96.204341509565,4,1,228,255,sp|P0DOX2|IGA2_HUMAN Immunoglobulin alpha-2 heavy chain OS=Homo sapiens OX=9606 PE=1 SV=2,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:5; HexNAc:2},2116.9056948598572,-2.4113281898831773e-06,17.5366815176,143.193909473,0,4991798897.5,28.4775525596,29.2198262916,28.628663745149,2;3,3,190,198,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:5; HexNAc:2},2116.9056948598572,-2.4113281898831773e-06,17.5366815176,143.193909473,0,4991798897.5,28.4775525596,29.2198262916,28.628663745149,2;3,3,546,554,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:6; HexNAc:2},2278.95975617139,-2.783044936602608e-06,18.1612934649,140.574687237,0,2275746394.0,28.257462075,28.601533944,28.380777727191,2;3,2,546,554,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:6; HexNAc:2},2278.95975617139,-2.783044936602608e-06,18.1612934649,140.574687237,0,2275746394.0,28.257462075,28.601533944,28.380777727191,2;3,2,190,198,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:7; HexNAc:2},2441.0102183988124,-1.6309871635411292e-06,17.2855406682,125.275316945,0,1809965724.25,28.1054493414,28.4775525596,28.257462074979,2;3,2,546,554,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:7; HexNAc:2},2441.0102183988124,-1.6309871635411292e-06,17.2855406682,125.275316945,0,1809965724.25,28.1054493414,28.4775525596,28.257462074979,2;3,2,190,198,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:8; HexNAc:2},2603.0620958330164,-1.1660390435066386e-06,17.0480299517,124.955582447,0,1309840693.5,27.9964091446,28.2439286417,28.119264358902,2;3,2,190,198,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:8; HexNAc:2},2603.0620958330164,-1.1660390435066386e-06,17.0480299517,124.955582447,0,1309840693.5,27.9964091446,28.2439286417,28.119264358902,2;3,2,546,554,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
TLTLFN(N-Glycosylation)VTR{Hex:5; HexNAc:2},2280.0324045793573,-3.047375078370458e-06,12.4289007436,122.753180049,0,299737944.75,66.1615913775,66.5444705433,66.328174124781,2,2,198,207,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
TLTLFN(N-Glycosylation)VTR{Hex:5; HexNAc:2},2280.0324045793573,-3.047375078370458e-06,12.4289007436,122.753180049,0,299737944.75,66.1615913775,66.5444705433,66.328174124781,2,2,554,563,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:3; HexNAc:2},1792.8006785242014,-3.1989366080767427e-06,13.7665057848,109.949281301,0,153786412.5,29.0004329588,29.1925246583,29.09677742583,2,2,546,554,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:3; HexNAc:2},1792.8006785242014,-3.1989366080767427e-06,13.7665057848,109.949281301,0,153786412.5,29.0004329588,29.1925246583,29.09677742583,2,2,190,198,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
TLTLFN(N-Glycosylation)VTR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3123.3654149119216,-8.92886305540983e-06,-4.01859634251,78.2555178585,0,17867655.75,70.3502827114,70.4444644914,70.397895759964,3,2,554,563,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
TLTLFN(N-Glycosylation)VTR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3123.3654149119216,-8.92886305540983e-06,-4.01859634251,78.2555178585,0,17867655.75,70.3502827114,70.4444644914,70.397895759964,3,2,198,207,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
TLTLFN(N-Glycosylation)VTR{Fuc:3; Hex:5; HexNAc:4; Neu5Ac:1},3415.45809334,-1.39042313524e-06,0,65.6786280586,0,0,,,,3,1,554,563,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,
TLTLFN(N-Glycosylation)VTR{Fuc:3; Hex:5; HexNAc:4; Neu5Ac:1},3415.45809334,-1.39042313524e-06,0,65.6786280586,0,0,,,,3,1,198,207,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,
TLTLFN(N-Glycosylation)VTR{Fuc:3; Hex:5; HexNAc:4},3124.36522069,-2.33416643212e-06,0,65.6272924187,0,0,,,,3,1,554,563,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,
TLTLFN(N-Glycosylation)VTR{Fuc:3; Hex:5; HexNAc:4},3124.36522069,-2.33416643212e-06,0,65.6272924187,0,0,,,,3,1,198,207,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,
TLTLFN(N-Glycosylation)VTR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3414.4528609332747,-5.833326086525791e-06,13.1088540753,64.9148175527,0,1164445712.5,77.4944015092,78.9567523267,78.238460710271,3,6,554,563,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
TLTLFN(N-Glycosylation)VTR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3414.4528609332747,-5.833326086525791e-06,13.1088540753,64.9148175527,0,1164445712.5,77.4944015092,78.9567523267,78.238460710271,3,6,198,207,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:5; HexNAc:4; Neu5Ac:2},3105.262568529215,-3.993276414399526e-06,11.4947851804,61.91120424,0,563249736.0,33.8523032413,35.0169905768,34.615839674695,3,2,546,554,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:5; HexNAc:4; Neu5Ac:2},3105.262568529215,-3.993276414399526e-06,11.4947851804,61.91120424,0,563249736.0,33.8523032413,35.0169905768,34.615839674695,3,2,190,198,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
TLTLFN(N-Glycosylation)VTR{Fuc:3; Hex:5; HexNAc:5},3327.4213839242375,4.78343278655845e-06,10.8124320551,59.450787944,0,41677312,43.3594821439,43.4758732583,43.403563311323,3,2,554,563,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
TLTLFN(N-Glycosylation)VTR{Fuc:3; Hex:5; HexNAc:5},3327.4213839242375,4.78343278655845e-06,10.8124320551,59.450787944,0,41677312,43.3594821439,43.4758732583,43.403563311323,3,2,198,207,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,Unmodified
TLTLFN(N-Glycosylation)VTRNDAR{Fuc:3; Hex:6; HexNAc:5},3945.71403157,-4.00750206535e-06,0,10.9105511606,0.0331491712707,0,,,,3,1,554,567,sp|P06731|CEAM5_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 5 OS=Homo sapiens OX=9606 GN=CEACAM5 PE=1 SV=4,
N(N-Glycosylation)LTKLK{Hex:9; HexNAc:4},2986.2612055118643,-3.040622098933429e-06,14.2066854721,71.2424912418,0,322778438.75,41.4193392422,41.96592541,41.568836592261,3,2,1023,1029,sp|P35749|MYH11_HUMAN Myosin-11 OS=Homo sapiens OX=9606 GN=MYH11 PE=1 SV=3,Unmodified
AKN(N-Glycosylation)LTK{Fuc:2; Hex:7; HexNAc:6; Neu5Ac:1},3609.46518697,1.19700955302e-06,0,38.9936425538,0,0,,,,3,1,1021,1027,sp|P35749|MYH11_HUMAN Myosin-11 OS=Homo sapiens OX=9606 GN=MYH11 PE=1 SV=3,
NEEYN(N-Glycosylation)K{Hex:5; HexNAc:4; Neu5Ac:2},3000.1188532505603,-2.1718401600006066e-06,13.526114427,55.3053915844,0,390938931.75,25.2589033948,26.0457511451,25.664596158886,3,2,51,57,sp|P02763|A1AG1_HUMAN Alpha-1-acid glycoprotein 1 OS=Homo sapiens OX=9606 GN=ORM1 PE=1 SV=2,Unmodified
HN(N-Glycosylation)KTTAQVLIR{Fuc:1; Hex:4; HexNAc:8},3698.6381954427916,5.556913300470779e-07,12.3526911189,15.8911303566,0,201457860,44.9050692425,45.1223908768,45.050658327961,4,2,240,251,sp|P15121|ALDR_HUMAN Aldo-keto reductase family 1 member B1 OS=Homo sapiens OX=9606 GN=AKR1B1 PE=1 SV=3,Unmodified
VTKN(N-Glycosylation)VSKPR{Fuc:1; Hex:9; HexNAc:4},3444.48349456,-5.47460665456e-06,0,19.0414444018,0,0,,,,3,1,16,25,sp|Q9Y3U8|RL36_HUMAN Large ribosomal subunit protein eL36 OS=Homo sapiens OX=9606 GN=RPL36 PE=1 SV=3,
C(Carbamidomethyl)RPN(N-Glycosylation)VTGRR{Fuc:1; Hex:4; HexNAc:4; Neu5Ac:1},3012.2542519558656,1.8760145330898484e-06,15.3489472428,87.4504176521,0,1035941592.25,37.9478007422,38.7766964104,38.272261125469,2;3,4,1551,1560,sp|O15230|LAMA5_HUMAN Laminin subunit alpha-5 OS=Homo sapiens OX=9606 GN=LAMA5 PE=1 SV=8,Unmodified
GEDVN(N-Glycosylation)RTLEGGR{Fuc:1; Hex:4; HexNAc:3},2705.1456041280258,-2.178516563698833e-06,-6.77124069654,10.6874322031,0.0331491712707,16086970.25,44.4284636444,44.6995499756,44.428463644409,2,1,24,36,sp|P58546|MTPN_HUMAN Myotrophin OS=Homo sapiens OX=9606 GN=MTPN PE=1 SV=2,Unmodified
N(N-Glycosylation)ATVVWMKDNIR{Fuc:2; Hex:7; HexNAc:4},3684.538304673148,2.628681794230547e-06,9.54533802366,19.4296107178,0,66305919.5,78.3149414923,78.6751039928,78.471663227304,3,2,360,372,sp|Q13740|CD166_HUMAN CD166 antigen OS=Homo sapiens OX=9606 GN=ALCAM PE=1 SV=2,Unmodified
VLN(N-Glycosylation)KTM(Oxidation)DVSKLSAEK{Hex:5; HexNAc:4; Neu5Ac:1},3591.59532994,-5.89827839832e-06,0,10.3658865326,0.0434782608696,0,,,,3,1,195,210,sp|P25789|PSA4_HUMAN Proteasome subunit alpha type-4 OS=Homo sapiens OX=9606 GN=PSMA4 PE=1 SV=1,
TVDKKN(N-Glycosylation)ISEK{Fuc:1; Hex:5; HexNAc:4},2929.2760701831608,1.2111619642935035e-06,9.95801338826,57.3478400255,0,50185969,37.6314577923,37.760336211,37.67470617555,3,1,1293,1303,sp|Q14966|ZN638_HUMAN Zinc finger protein 638 OS=Homo sapiens OX=9606 GN=ZNF638 PE=1 SV=2,Unmodified
ALVN(N-Glycosylation)FTR{Hex:7; HexNAc:5; Neu5Ac:2},3551.427955195294,-2.874463670134513e-06,13.5557925103,86.9390269971,0,1115822038.0,67.8279253588,69.0537622597,68.571448594952,3,4,85,92,sp|P98160|PGBM_HUMAN Basement membrane-specific heparan sulfate proteoglycan core protein OS=Homo sapiens OX=9606 GN=HSPG2 PE=1 SV=4,Unmodified
N(N-Glycosylation)MTLFSDLVAEK{Fuc:2; Hex:6; HexNAc:4},3443.466355337431,-1.0412341969234185e-05,9.93872288582,86.9962904691,0,118063279.5,81.7551478611,82.1317707763,81.989891642952,3,4,784,796,sp|P12110|CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens OX=9606 GN=COL6A2 PE=1 SV=4,Unmodified
GTFTDC(Carbamidomethyl)ALAN(N-Glycosylation)MTEQIR{Fuc:1; Hex:5; HexNAc:3},3392.39243857,-9.36240157371e-07,0,24.3414567965,0,0,,,,3,1,130,146,sp|P12110|CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens OX=9606 GN=COL6A2 PE=1 SV=4,
N(N-Glycosylation)MTLFSDLVAEK{Hex:7; HexNAc:6},3719.54320858,-4.55887481853e-06,0,13.8883256096,0,0,,,,3,1,784,796,sp|P12110|CO6A2_HUMAN Collagen alpha-2(VI) chain OS=Homo sapiens OX=9606 GN=COL6A2 PE=1 SV=4,
VRGVN(N-Glycosylation)ASAQK{Fuc:1; Hex:6; HexNAc:5; Neu5Ac:1},3453.43871158,3.20846067453e-07,0,11.1087621264,0.0229885057471,0,,,,3,1,583,593,"sp|Q01082|SPTB2_HUMAN Spectrin beta chain, non-erythrocytic 1 OS=Homo sapiens OX=9606 GN=SPTBN1 PE=1 SV=2",
VPTAN(N-Glycosylation)VSVVDLTC(Carbamidomethyl)R{Fuc:3; Hex:5; HexNAc:7},4199.77282243,1.8587331387e-06,0,12.6793005531,0.0122699386503,0,,,,3,1,234,248,sp|P04406|G3P_HUMAN Glyceraldehyde-3-phosphate dehydrogenase OS=Homo sapiens OX=9606 GN=GAPDH PE=1 SV=3,
N(N-Glycosylation)KTRVVSYR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3181.3625610691192,9.152757739997693e-07,13.0774793711,75.0148151114,0,179101027.5,29.3715999947,29.5948899613,29.428448278332,3,2,452,461,sp|Q14764|MVP_HUMAN Major vault protein OS=Homo sapiens OX=9606 GN=MVP PE=1 SV=4,Unmodified
N(N-Glycosylation)KTRVVSYR{Fuc:1; Hex:5; HexNAc:5; Neu5Ac:2},3675.542019492927,-4.781808336508065e-07,16.2538123978,59.2356134603,0,1382654823.0,31.2540548748,31.7699037618,31.439030375703,3;4,3,452,461,sp|Q14764|MVP_HUMAN Major vault protein OS=Homo sapiens OX=9606 GN=MVP PE=1 SV=4,Unmodified
N(N-Glycosylation)KTRVVSYR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3472.46187253422,-2.831232094650829e-07,12.8142493166,44.9088550501,0,570283025.0,31.153596527,31.6969536768,31.310670875136,3;4,2,452,461,sp|Q14764|MVP_HUMAN Major vault protein OS=Homo sapiens OX=9606 GN=MVP PE=1 SV=4,Unmodified
TAN(N-Glycosylation)DTSTEAYNLLLR{Hex:5; HexNAc:2},2897.2721728328816,-6.0167481970066794e-06,11.1069195502,111.40139388,0,292038095.75,67.3219567285,67.6606779085,67.492766661072,2;3,2,1202,1217,sp|P11047|LAMC1_HUMAN Laminin subunit gamma-1 OS=Homo sapiens OX=9606 GN=LAMC1 PE=1 SV=3,Unmodified
N(N-Glycosylation)LTALR{Hex:5; HexNAc:2},1902.8358318360742,-2.8622273363642804e-06,10.813439662,112.780015238,0,123307785.0,33.69537411,33.9820378091,33.79382152818,2,2,341,347,sp|Q13753|LAMC2_HUMAN Laminin subunit gamma-2 OS=Homo sapiens OX=9606 GN=LAMC2 PE=1 SV=2,Unmodified
N(N-Glycosylation)LTALRIR{Fuc:1; Hex:8; HexNAc:8; Neu5Ac:2},4604.877628410909,4.642742614609801e-06,13.1849466912,62.7261814579,0,997207608.0,86.6807772782,87.3548609084,87.135831775888,3;4,4,341,349,sp|Q13753|LAMC2_HUMAN Laminin subunit gamma-2 OS=Homo sapiens OX=9606 GN=LAMC2 PE=1 SV=2,Unmodified
LN(N-Glycosylation)DTVGVTK{Hex:5; HexNAc:2},2161.943313564574,-3.3954682521823738e-06,14.7635982507,108.968398729,0,177332541.0,30.9417883581,31.1819100446,31.027413792038,2,2,2749,2758,sp|Q16787|LAMA3_HUMAN Laminin subunit alpha-3 OS=Homo sapiens OX=9606 GN=LAMA3 PE=1 SV=3,Unmodified
FN(N-Glycosylation)KTKTFR{Hex:9; HexNAc:5; Neu5Ac:1},3805.543245109266,3.044770269777798e-07,8.49477521247,73.0899843701,0,190387009.0,72.628230626,73.2276113099,72.7830023434,3;4,5,2943,2951,sp|Q16787|LAMA3_HUMAN Laminin subunit alpha-3 OS=Homo sapiens OX=9606 GN=LAMA3 PE=1 SV=3,Unmodified
TVLEN(N-Glycosylation)STSYEEAK{Hex:5; HexNAc:2},2686.125510799329,-5.241866868087387e-06,11.9040043786,95.6409746018,0,96986478.75,35.3097825434,35.6470736927,35.470779993757,2,2,254,267,sp|Q13510|ASAH1_HUMAN Acid ceramidase OS=Homo sapiens OX=9606 GN=ASAH1 PE=1 SV=5,Unmodified
LPGREN(N-Glycosylation)K{Fuc:3; Hex:5; HexNAc:4; Neu5Ac:1},3164.31127309,-3.18306829864e-06,0,58.619667029,0,0,,,,3,1,71,78,sp|Q07020|RL18_HUMAN Large ribosomal subunit protein eL18 OS=Homo sapiens OX=9606 GN=RPL18 PE=1 SV=2,
HRN(N-Glycosylation)RSFSR{Fuc:6; Hex:8; HexNAc:8},4855.948075012101,1.061185407971609e-06,-4.66486186736,71.2769746543,0,38022598,69.4520241446,69.6364116099,69.528241211796,4,1,166,174,sp|O75494|SRS10_HUMAN Serine/arginine-rich splicing factor 10 OS=Homo sapiens OX=9606 GN=SRSF10 PE=1 SV=1,Unmodified
LLEN(N-Glycosylation)M(Oxidation)TEVVRK{Fuc:1; Hex:6; HexNAc:5},3480.475864815003,5.353748519046558e-06,13.1073151421,55.6917493304,0,78975912.5,25.9861602094,26.0892100599,26.045751145109,3;4,1,604,615,sp|Q6P996|PDXD1_HUMAN Pyridoxal-dependent decarboxylase domain-containing protein 1 OS=Homo sapiens OX=9606 GN=PDXDC1 PE=1 SV=2,Unmodified
VN(N-Glycosylation)KTSK{Fuc:1; Hex:8; HexNAc:8},3742.501979901969,1.3454474006778632e-06,11.3253524245,86.669543819,0,147622805.75,41.2427288757,41.4650194274,41.315689276282,4;5,1,1053,1059,sp|Q86UP2|KTN1_HUMAN Kinectin OS=Homo sapiens OX=9606 GN=KTN1 PE=1 SV=1,Unmodified
LVLIN(N-Glycosylation)K{Fuc:4; Hex:6; HexNAc:5; Neu5Ac:1},3561.5207977,-3.05540983981e-06,0,35.374362548,0,0,,,,3,1,804,810,sp|O60716|CTND1_HUMAN Catenin delta-1 OS=Homo sapiens OX=9606 GN=CTNND1 PE=1 SV=1,
IIVPLNNREN(N-Glycosylation)ISDPTSPLR{Hex:5; HexNAc:4; Neu5Ac:1},4060.876928085,-7.397077100067695e-06,11.2166420723,18.273033704,0,142054533.75,65.4847207612,65.7464978085,65.546177759393,3,1,61,80,sp|P01591|IGJ_HUMAN Immunoglobulin J chain OS=Homo sapiens OX=9606 GN=JCHAIN PE=1 SV=4,Unmodified
AVDLLN(N-Glycosylation)YTQWFPIVIFFNPDSRQGVKTM(Oxidation)R{Fuc:3; Hex:6; HexNAc:5},5896.67127829,-4.80233013885e-07,0,13.0578111497,0.0062893081761,0,,,,4,1,796,825,sp|Q9UDY2|ZO2_HUMAN Tight junction protein ZO-2 OS=Homo sapiens OX=9606 GN=TJP2 PE=1 SV=2,
KAN(N-Glycosylation)STR{Fuc:4; Hex:6; HexNAc:6; Neu5Ac:1},3741.4940962266246,-1.9997563306067853e-06,-4.12094284387,44.0150931156,0,35389690,41.2721426116,41.3898043778,41.272142611567,4,1,1245,1251,sp|Q00610|CLH1_HUMAN Clathrin heavy chain 1 OS=Homo sapiens OX=9606 GN=CLTC PE=1 SV=5,Unmodified
MPGGLLLGDVAPNFEAN(N-Glycosylation)TTVGR{Hex:5; HexNAc:2},3444.527297333553,6.246769747677993e-06,12.4226754395,16.2901175273,0,205677939.0,81.2270154105,81.5550595945,81.336355025196,3,2,0,22,sp|P30041|PRDX6_HUMAN Peroxiredoxin-6 OS=Homo sapiens OX=9606 GN=PRDX6 PE=1 SV=3,Unmodified
LLYN(N-Glycosylation)STDPTLR{Fuc:4; Hex:6; HexNAc:5},3863.60977606,3.33317066579e-06,0,12.7600716148,0.0122699386503,0,,,,3,1,545,556,sp|B0I1T2|MYO1G_HUMAN Unconventional myosin-Ig OS=Homo sapiens OX=9606 GN=MYO1G PE=1 SV=2,
LQLSNGN(N-Glycosylation)R{Hex:5; HexNAc:2},2116.9056948598572,-2.4113281898831773e-06,17.5366815176,143.193909473,0,4991798897.5,28.4775525596,29.2198262916,28.628663745149,2;3,3,190,198,sp|P13688|CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens OX=9606 GN=CEACAM1 PE=1 SV=2,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:6; HexNAc:2},2278.95975617139,-2.783044936602608e-06,18.1612934649,140.574687237,0,2275746394.0,28.257462075,28.601533944,28.380777727191,2;3,2,190,198,sp|P13688|CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens OX=9606 GN=CEACAM1 PE=1 SV=2,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:7; HexNAc:2},2441.0102183988124,-1.6309871635411292e-06,17.2855406682,125.275316945,0,1809965724.25,28.1054493414,28.4775525596,28.257462074979,2;3,2,190,198,sp|P13688|CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens OX=9606 GN=CEACAM1 PE=1 SV=2,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:8; HexNAc:2},2603.0620958330164,-1.1660390435066386e-06,17.0480299517,124.955582447,0,1309840693.5,27.9964091446,28.2439286417,28.119264358902,2;3,2,190,198,sp|P13688|CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens OX=9606 GN=CEACAM1 PE=1 SV=2,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:3; HexNAc:2},1792.8006785242014,-3.1989366080767427e-06,13.7665057848,109.949281301,0,153786412.5,29.0004329588,29.1925246583,29.09677742583,2,2,190,198,sp|P13688|CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens OX=9606 GN=CEACAM1 PE=1 SV=2,Unmodified
LQLSNGN(N-Glycosylation)R{Hex:5; HexNAc:4; Neu5Ac:2},3105.262568529215,-3.993276414399526e-06,11.4947851804,61.91120424,0,563249736.0,33.8523032413,35.0169905768,34.615839674695,3,2,190,198,sp|P13688|CEAM1_HUMAN Carcinoembryonic antigen-related cell adhesion molecule 1 OS=Homo sapiens OX=9606 GN=CEACAM1 PE=1 SV=2,Unmodified
RN(N-Glycosylation)ISRIDLLAQPR{Hex:7; HexNAc:5; Neu5Ac:1},3991.785992858445,-5.872597846366651e-06,13.4380957976,11.0483601926,0,475469211.5,64.6890126254,65.3161066916,64.95230965875,3;4,3,1141,1154,sp|Q5SW79|CE170_HUMAN Centrosomal protein of 170 kDa OS=Homo sapiens OX=9606 GN=CEP170 PE=1 SV=1,Unmodified
LEN(N-Glycosylation)VSVALEFLEREHIKLVSIDSK{Fuc:3; Hex:5; HexNAc:4; Neu5Ac:1},5119.36435173,-3.13854635053e-07,0,19.2836971235,0,0,,,,4,1,96,120,sp|Q14315|FLNC_HUMAN Filamin-C OS=Homo sapiens OX=9606 GN=FLNC PE=1 SV=3,
QMGGNTNTGAALN(N-Glycosylation)FTLSLLQKAK{Fuc:2; Hex:5; HexNAc:4},4291.935667045114,9.63860865058202e-07,-21.5635222956,12.1490115742,0.0180722891566,7214282.0,78.5192253099,78.5964064942,78.596406494204,3,1,507,530,sp|A6NMZ7|CO6A6_HUMAN Collagen alpha-6(VI) chain OS=Homo sapiens OX=9606 GN=COL6A6 PE=1 SV=2,Unmodified
ISESLRTVN(N-Glycosylation)MTWNK{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},3883.62981832,3.56963018039e-06,0,18.1394039039,0,0,,,,3,1,2159,2173,sp|P46939|UTRN_HUMAN Utrophin OS=Homo sapiens OX=9606 GN=UTRN PE=1 SV=2,
IIQRN(N-Glycosylation)R{Fuc:3; Hex:6; HexNAc:6},3427.45159366,-6.62884119049e-07,0,93.9498295604,0,0,,,,3,1,582,588,"sp|P13807|GYS1_HUMAN Glycogen [starch] synthase, muscle OS=Homo sapiens OX=9606 GN=GYS1 PE=1 SV=2",
IIQRN(N-Glycosylation)R{Fuc:1; Hex:6; HexNAc:6},3135.351973602853,-5.890740315154852e-06,13.8230795838,70.8997658507,0,151051296.5,76.3300190117,76.6890844093,76.501863676929,3,2,582,588,"sp|P13807|GYS1_HUMAN Glycogen [starch] synthase, muscle OS=Homo sapiens OX=9606 GN=GYS1 PE=1 SV=2",Unmodified
IIQRN(N-Glycosylation)R{Fuc:1; Hex:6; HexNAc:7; Neu5Ac:1},3629.5131458400147,-1.337026554246936e-06,-21.0801653191,64.7161606468,0,4869301.5,62.0522786445,62.0522786445,62.052278644466,3,1,582,588,"sp|P13807|GYS1_HUMAN Glycogen [starch] synthase, muscle OS=Homo sapiens OX=9606 GN=GYS1 PE=1 SV=2",Unmodified
IIQRN(N-Glycosylation)R{Fuc:1; Hex:6; HexNAc:6; Neu5Ac:2},3717.547837689299,-6.321537423354569e-06,-5.96626132952,42.6371637749,0,14220846.75,88.9704340444,89.240359595,89.240359595044,3,1,582,588,"sp|P13807|GYS1_HUMAN Glycogen [starch] synthase, muscle OS=Homo sapiens OX=9606 GN=GYS1 PE=1 SV=2",Unmodified
IIQRN(N-Glycosylation)R{Fuc:2; Hex:6; HexNAc:6},3281.40306121,-3.54980840613e-06,0,42.3288293894,0,0,,,,3,1,582,588,"sp|P13807|GYS1_HUMAN Glycogen [starch] synthase, muscle OS=Homo sapiens OX=9606 GN=GYS1 PE=1 SV=2",
LNLN(N-Glycosylation)NTVLSKRK{Fuc:2; Hex:6; HexNAc:5},3678.65218474,2.21079409295e-06,0,17.2261836178,0,0,,,,3,1,425,437,sp|P07814|SYEP_HUMAN Bifunctional glutamate/proline--tRNA ligase OS=Homo sapiens OX=9606 GN=EPRS1 PE=1 SV=5,
KN(N-Glycosylation)LTLSK{Fuc:1; Hex:6; HexNAc:6},3139.342368998158,-1.006305599505245e-08,13.940574734,79.1650245738,0,166479284,28.9175344771,29.0688625441,28.94493252697,3,2,924,931,sp|Q96Q89|KI20B_HUMAN Kinesin-like protein KIF20B OS=Homo sapiens OX=9606 GN=KIF20B PE=1 SV=3,Unmodified
N(N-Glycosylation)LTLSK{Fuc:4; Hex:8; HexNAc:7},3976.61154304,-1.36369708768e-06,0,33.5067510042,0,0,,,,3,1,925,931,sp|Q96Q89|KI20B_HUMAN Kinesin-like protein KIF20B OS=Homo sapiens OX=9606 GN=KIF20B PE=1 SV=3,
EELQEKN(N-Glycosylation)VTLDVQIQHVVEGK{Fuc:1; Hex:5; HexNAc:3; Neu5Ac:1},4290.910296631108,3.6428168898371195e-06,-4.89595866889,14.9304165198,0,21365243.0,78.5652652767,78.7846327092,78.565265276655,3,1,1125,1146,sp|Q96Q89|KI20B_HUMAN Kinesin-like protein KIF20B OS=Homo sapiens OX=9606 GN=KIF20B PE=1 SV=3,Unmodified
LIC(Carbamidomethyl)N(N-Glycosylation)ETVEVPK{Fuc:1; Hex:7; HexNAc:4},3393.40003225,4.36693394204e-06,0,10.5912663775,0.0331491712707,0,,,,3,1,810,821,sp|Q96Q89|KI20B_HUMAN Kinesin-like protein KIF20B OS=Homo sapiens OX=9606 GN=KIF20B PE=1 SV=3,
SELVN(N-Glycosylation)ETR{Hex:5; HexNAc:2},2162.8991978743493,-2.016578328663958e-06,16.2975361737,119.643154137,0,342158984.0,28.2711615589,28.4918199923,28.380777727191,2,2,157,165,sp|Q9UGT4|SUSD2_HUMAN Sushi domain-containing protein 2 OS=Homo sapiens OX=9606 GN=SUSD2 PE=1 SV=1,Unmodified
N(N-Glycosylation)FTVSAVIFKK{Fuc:1; Hex:6; HexNAc:5; Neu5Ac:1},3677.6104399523324,-6.893905558125769e-06,9.67364027353,39.9826203912,0,110986833.0,83.5892441259,83.9028257595,83.683630059783,3,3,154,165,sp|Q08999|RBL2_HUMAN Retinoblastoma-like protein 2 OS=Homo sapiens OX=9606 GN=RBL2 PE=1 SV=3,Unmodified
N(N-Glycosylation)FTVSAVIFKK{Fuc:2; Hex:7; HexNAc:5},3694.6202731,-5.37823483112e-06,0,35.5363246196,0,0,,,,3,1,154,165,sp|Q08999|RBL2_HUMAN Retinoblastoma-like protein 2 OS=Homo sapiens OX=9606 GN=RBL2 PE=1 SV=3,
LILDN(N-Glycosylation)DTIK{Fuc:1; Hex:8; HexNAc:7},3907.619657423185,6.965682419451579e-07,14.1750557911,55.1290360622,0,353114704.5,71.3855228609,71.8484568423,71.585590059185,3,2,405,414,sp|Q8WXX0|DYH7_HUMAN Dynein axonemal heavy chain 7 OS=Homo sapiens OX=9606 GN=DNAH7 PE=1 SV=2,Unmodified
LILDN(N-Glycosylation)DTIK{Fuc:1; Hex:8; HexNAc:7; Neu5Ac:1},4198.728786274918,-2.617559282166395e-06,11.3052374275,49.3954732292,0,21946360.25,75.8456283278,76.0324008094,75.970824144904,3,2,405,414,sp|Q8WXX0|DYH7_HUMAN Dynein axonemal heavy chain 7 OS=Homo sapiens OX=9606 GN=DNAH7 PE=1 SV=2,Unmodified
LILDN(N-Glycosylation)DTIK{Fuc:1; Hex:5; HexNAc:5; Neu5Ac:1},3306.4023846023406,-5.45621264823507e-07,11.2550423033,17.585881849,0,176012616.0,56.8729635106,57.4314108596,57.263992041969,3,2,405,414,sp|Q8WXX0|DYH7_HUMAN Dynein axonemal heavy chain 7 OS=Homo sapiens OX=9606 GN=DNAH7 PE=1 SV=2,Unmodified
N(N-Glycosylation)LTNPNTVIILIGNK{Fuc:2; Hex:5; HexNAc:4},3537.636421111558,-9.72563482619073e-07,12.3104348193,16.2516133519,0,1135981226.0,66.0994778778,66.743837077,66.251403175418,3;4,2,110,125,sp|P61106|RAB14_HUMAN Ras-related protein Rab-14 OS=Homo sapiens OX=9606 GN=RAB14 PE=1 SV=4,Unmodified
N(N-Glycosylation)LTNPNTVIILIGNK{Fuc:1; Hex:5; HexNAc:5},3594.6781993901463,-6.6084174156431965e-06,12.9579622738,15.6902657572,0,219041946.75,61.6865611579,61.9295687264,61.777113209788,3;4,2,110,125,sp|P61106|RAB14_HUMAN Ras-related protein Rab-14 OS=Homo sapiens OX=9606 GN=RAB14 PE=1 SV=4,Unmodified
VREIRYQGGN(N-Glycosylation)R{Fuc:1; Hex:5; HexNAc:4},3115.3508615654678,1.728234459389434e-06,19.2642151596,85.451176462,0,764196999.75,25.8820470081,26.0744789269,25.9712248113,3;4,4,1564,1575,sp|P04275|VWF_HUMAN von Willebrand factor OS=Homo sapiens OX=9606 GN=VWF PE=1 SV=4,Unmodified
VREIRYQGGN(N-Glycosylation)R{Fuc:1; Hex:6; HexNAc:4},3277.404020545649,1.5403944705884632e-06,16.8287473452,80.5612382132,0,623208913.75,25.8379814412,26.0148731417,25.896744841957,3;4,2,1564,1575,sp|P04275|VWF_HUMAN von Willebrand factor OS=Homo sapiens OX=9606 GN=VWF PE=1 SV=4,Unmodified
LIQLMEEIM(Oxidation)AEKEN(N-Glycosylation)K{Hex:6; HexNAc:8; Neu5Ac:2},5013.081661340788,-3.4480051844372304e-06,-6.27395921281,22.4713295687,0,37370495,65.0891472246,65.2717705276,65.180108243847,5,1,405,420,sp|Q92841|DDX17_HUMAN Probable ATP-dependent RNA helicase DDX17 OS=Homo sapiens OX=9606 GN=DDX17 PE=1 SV=2,Unmodified
FN(N-Glycosylation)ASIAYDR{Fuc:3; Hex:5; HexNAc:4},3116.26382296,-1.56624213415e-06,0,14.1883248917,0.0251572327044,0,,,,3,1,23,32,sp|P04424|ARLY_HUMAN Argininosuccinate lyase OS=Homo sapiens OX=9606 GN=ASL PE=1 SV=4,
ERGRN(N-Glycosylation)WSR{Hex:5; HexNAc:2},2275.9542481025333,3.6792800085514814e-07,15.2134024315,101.201455233,0,741227761.75,61.3238756921,61.8841353919,61.550784093761,2;3,2,2117,2125,sp|Q9BTC0|DIDO1_HUMAN Death-inducer obliterator 1 OS=Homo sapiens OX=9606 GN=DIDO1 PE=1 SV=5,Unmodified
ERGRN(N-Glycosylation)WSR{Hex:6; HexNAc:2},2438.009105906254,-4.909735245742896e-07,14.017645022,95.8732748668,0,198522910.5,61.0007446434,61.4448887096,61.231770025317,2,2,2117,2125,sp|Q9BTC0|DIDO1_HUMAN Death-inducer obliterator 1 OS=Homo sapiens OX=9606 GN=DIDO1 PE=1 SV=5,Unmodified
TKLHN(N-Glycosylation)ESK{Fuc:4; Hex:7; HexNAc:7},4095.64747549,4.44989909159e-06,0,19.1259640298,0,0,,,,4,1,782,790,sp|Q9BTC0|DIDO1_HUMAN Death-inducer obliterator 1 OS=Homo sapiens OX=9606 GN=DIDO1 PE=1 SV=5,
LN(N-Glycosylation)LTTDPK{Fuc:1; Hex:7; HexNAc:8; Neu5Ac:1},4096.647002694383,6.623951746428122e-07,5.59644940149,29.9537088622,0,39244862.0,79.4887629932,80.0014390773,79.751669926071,3,2,163,171,sp|Q92896|GSLG1_HUMAN Golgi apparatus protein 1 OS=Homo sapiens OX=9606 GN=GLG1 PE=1 SV=2,Unmodified
N(N-Glycosylation)LTFNITKTIR{Fuc:1; Hex:5; HexNAc:5; Neu5Ac:2},3873.6862075183617,-5.253694324191881e-06,10.0290834436,56.4826622931,0,222718714,48.2611852275,48.5116068429,48.365079826736,3,4,147,158,sp|H3BS89|T178B_HUMAN Transmembrane protein 178B OS=Homo sapiens OX=9606 GN=TMEM178B PE=2 SV=1,Unmodified
N(N-Glycosylation)LTFNITKTIR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3670.6060392086847,-5.3275597724598e-06,-4.07835691144,55.8873603853,0,37921106,48.3049325413,48.3650798267,48.304932541275,3,3,147,158,sp|H3BS89|T178B_HUMAN Transmembrane protein 178B OS=Homo sapiens OX=9606 GN=TMEM178B PE=2 SV=1,Unmodified
NLTFN(N-Glycosylation)ITKTIR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3670.6060392086847,-5.3275597724598e-06,-4.07835691144,55.8873603853,0,37921106,48.3049325413,48.3650798267,48.304932541275,3,3,147,158,sp|H3BS89|T178B_HUMAN Transmembrane protein 178B OS=Homo sapiens OX=9606 GN=TMEM178B PE=2 SV=1,Unmodified
N(N-Glycosylation)LTFNITKTIRQDEWHALHLR{Fuc:1; Hex:6; HexNAc:4; Neu5Ac:2},5118.30958265,-7.55568841161e-06,0,21.2764244031,0,0,,,,4,1,147,168,sp|H3BS89|T178B_HUMAN Transmembrane protein 178B OS=Homo sapiens OX=9606 GN=TMEM178B PE=2 SV=1,
KLSPFN(N-Glycosylation)ITHR{Fuc:3; Hex:7; HexNAc:6},4002.70826914,-2.76140200504e-06,0,69.7662177062,0,0,,,,3,1,568,578,"sp|Q92835|SHIP1_HUMAN Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 OS=Homo sapiens OX=9606 GN=INPP5D PE=1 SV=2",
LSPFN(N-Glycosylation)ITHR{Fuc:1; Hex:7; HexNAc:4},3176.331578942745,-1.2242237620837545e-06,13.8293254517,68.4351145001,0,96836234.75,38.5862826095,38.7469950782,38.673497607931,3,2,569,578,"sp|Q92835|SHIP1_HUMAN Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 OS=Homo sapiens OX=9606 GN=INPP5D PE=1 SV=2",Unmodified
NEIKEN(N-Glycosylation)K{Fuc:1; Hex:6; HexNAc:4},2804.1380465271395,3.5264340507899123e-06,10.5600990107,99.9697083145,0,274102709,39.0509658442,39.3325116104,39.121576776727,2;3,3,442,449,sp|Q5RHP9|ERIC3_HUMAN Glutamate-rich protein 3 OS=Homo sapiens OX=9606 GN=ERICH3 PE=1 SV=1,Unmodified
YLLFN(N-Glycosylation)LSEK{Fuc:4; Hex:6; HexNAc:6},3900.65100511,-4.91796826605e-06,0,14.9041195309,0.0189873417722,0,,,,3,1,172,181,sp|Q63HR2|TENS2_HUMAN Tensin-2 OS=Homo sapiens OX=9606 GN=TNS2 PE=1 SV=2,
N(N-Glycosylation)QSVREFLDGTR{Fuc:1; Hex:8; HexNAc:3},3472.4149319255744,2.7565730372445294e-06,13.4333700368,22.0567862899,0,223116397.0,40.5617956108,41.0223763254,40.858241441472,3,1,170,182,sp|P29590|PML_HUMAN Protein PML OS=Homo sapiens OX=9606 GN=PML PE=1 SV=3,Unmodified
YKN(N-Glycosylation)NSDISSTR{Fuc:1; Hex:5; HexNAc:5; Neu5Ac:1},3546.4385892726677,-3.860622016507537e-06,14.1795524801,73.7480657554,0,208749948.5,25.6786299414,25.8530773586,25.737017944082,3;4,2,43,54,sp|P01871|IGHM_HUMAN Immunoglobulin heavy constant mu OS=Homo sapiens OX=9606 GN=IGHM PE=1 SV=5,Unmodified
ADTHDEILEGLNFN(N-Glycosylation)LTEIPEAQIHEGFQELLR{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},5896.64844129,-6.61913062133e-06,0,49.7525739863,0,0,,,,4,1,93,125,sp|P01009|A1AT_HUMAN Alpha-1-antitrypsin OS=Homo sapiens OX=9606 GN=SERPINA1 PE=1 SV=3,
VTDALN(N-Glycosylation)ATR{Fuc:1; Hex:7; HexNAc:4; Neu5Ac:1},3343.3524005196678,-2.456408150781279e-06,16.2317596482,74.7304928944,0,272748723.0,25.5179211762,25.7370179441,25.605416542912,3,2,420,429,"sp|P10809|CH60_HUMAN 60 kDa heat shock protein, mitochondrial OS=Homo sapiens OX=9606 GN=HSPD1 PE=1 SV=2",Unmodified
ETN(N-Glycosylation)LSTK{Fuc:1; Hex:5; HexNAc:6},2966.2045393486346,-1.274623868388475e-06,11.2588482424,79.6004299783,0,129233053.5,38.7176793085,39.0226865596,38.821153659248,3,2,1678,1685,sp|Q92817|EVPL_HUMAN Envoplakin OS=Homo sapiens OX=9606 GN=EVPL PE=1 SV=3,Unmodified
VQPRVN(N-Glycosylation)VSPSK{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3269.411500718173,1.9580498525676105e-06,9.21124612328,70.4734546999,0,149029311.75,69.6998782581,70.2561528749,69.855980291589,3,4,121,132,"sp|P04440|DPB1_HUMAN HLA class II histocompatibility antigen, DP beta 1 chain OS=Homo sapiens OX=9606 GN=HLA-DPB1 PE=1 SV=1",Unmodified
EHPAARQIELDLN(N-Glycosylation)R{Hex:6; HexNAc:5; Neu5Ac:1},3939.67237,3.46653325943e-07,0,22.4115250541,0,0,,,,3,1,662,676,sp|Q9BYX2|TBD2A_HUMAN TBC1 domain family member 2A OS=Homo sapiens OX=9606 GN=TBC1D2 PE=1 SV=3,
QIELDLN(N-Glycosylation)RTFPNNK{Hex:5; HexNAc:3},3120.4141752121186,-8.767341805495904e-06,12.7929640743,16.1315333939,0,88874483.0,81.8797807918,82.1317707763,82.08482495807,3,1,668,682,sp|Q9BYX2|TBD2A_HUMAN TBC1 domain family member 2A OS=Homo sapiens OX=9606 GN=TBC1D2 PE=1 SV=3,Unmodified
KLPPGLLAN(N-Glycosylation)FTLLR{Fuc:2; Hex:5; HexNAc:4; Neu5Ac:1},3757.77330577,-8.08480444644e-06,0,14.1889317321,0,0,,,,3,1,177,191,sp|P02750|A2GL_HUMAN Leucine-rich alpha-2-glycoprotein OS=Homo sapiens OX=9606 GN=LRG1 PE=1 SV=2,
N(N-Glycosylation)DSLRK{Fuc:1; Hex:4; HexNAc:3},2134.891217385805,4.077122648750578e-06,15.0462744525,38.8417598424,0,164254467.5,26.4839537448,26.6659355945,26.580466793601,2,2,187,193,sp|Q15631|TSN_HUMAN Translin OS=Homo sapiens OX=9606 GN=TSN PE=1 SV=1,Unmodified
GFFNLN(N-Glycosylation)RSSKR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:1},3384.4432823031757,-2.462108870076468e-06,9.38547069064,68.8342690997,0,227433216.0,29.4557307587,29.8745986925,29.511794875685,3,2,43,54,sp|Q92614|MY18A_HUMAN Unconventional myosin-XVIIIa OS=Homo sapiens OX=9606 GN=MYO18A PE=1 SV=3,Unmodified
LN(N-Glycosylation)WTSLLPASFTKNYKPVVQTTGNAR{Fuc:2; Hex:5; HexNAc:4},4820.29023007042,-9.912041200772814e-06,-20.7632010191,28.5743146637,0,28469156,96.2194590913,96.2194590913,96.21945909125,4,1,285,311,sp|Q6PIU2|NCEH1_HUMAN Neutral cholesterol ester hydrolase 1 OS=Homo sapiens OX=9606 GN=NCEH1 PE=1 SV=3,Unmodified
RTVN(N-Glycosylation)STR{Fuc:1; Hex:7; HexNAc:4},2925.1783741687073,6.256734308745265e-06,16.0234863399,83.2970978984,0,420829371.75,38.3940252092,38.7766964104,38.571165194734,2;3,2,42,49,sp|Q5SSJ5|HP1B3_HUMAN Heterochromatin protein 1-binding protein 3 OS=Homo sapiens OX=9606 GN=HP1BP3 PE=1 SV=1,Unmodified
FEVFKN(N-Glycosylation)GTLR{Fuc:3; Hex:5; HexNAc:5},3473.4840178,3.72951959216e-07,0,12.4617542668,0.0122699386503,0,,,,3,1,457,467,sp|Q13308|PTK7_HUMAN Inactive tyrosine-protein kinase 7 OS=Homo sapiens OX=9606 GN=PTK7 PE=1 SV=2,
IKGC(Carbamidomethyl)TDN(N-Glycosylation)LTLTVAR{Fuc:3; Hex:6; HexNAc:5},3986.73015898,-3.32421506391e-06,0,11.3945805592,0.0229885057471,0,,,,3,1,69,83,sp|O00151|PDLI1_HUMAN PDZ and LIM domain protein 1 OS=Homo sapiens OX=9606 GN=PDLIM1 PE=1 SV=4,
N(N-Glycosylation)VTVKTIK{Fuc:2; Hex:6; HexNAc:4; Neu5Ac:2},3560.5151053434993,-4.032352186354401e-06,8.24323151863,38.7581780968,0,132257398.0,77.6492771413,78.1168112582,77.790075845146,3,3,258,266,sp|Q99733|NP1L4_HUMAN Nucleosome assembly protein 1-like 4 OS=Homo sapiens OX=9606 GN=NAP1L4 PE=1 SV=1,Unmodified
N(N-Glycosylation)ASNTEKLTDQVMQNPR{Fuc:1; Hex:8; HexNAc:8},5012.075638324545,-5.551407977960734e-06,11.9844985628,17.62751722,0,139700219.5,65.1496821747,65.362320692,65.210192575677,4;5,1,19,36,sp|Q99733|NP1L4_HUMAN Nucleosome assembly protein 1-like 4 OS=Homo sapiens OX=9606 GN=NAP1L4 PE=1 SV=1,Unmodified
ETPPNGN(N-Glycosylation)LSPAPRLR{Fuc:1; Hex:5; HexNAc:4; Neu5Ac:2},3968.734274115315,-1.1394742253338763e-05,-20.5952484561,21.4288339872,0,4316816,89.240359595,89.240359595,89.240359595044,3,2,995,1010,sp|P48634|PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens OX=9606 GN=PRRC2A PE=1 SV=3,Unmodified
ETPPNGN(N-Glycosylation)LSPAPRLR{Fuc:1; Hex:5; HexNAc:4},3386.51976133,-6.36137774442e-06,0,16.5562158496,0,0,,,,3,1,995,1010,sp|P48634|PRC2A_HUMAN Protein PRRC2A OS=Homo sapiens OX=9606 GN=PRRC2A PE=1 SV=3,
VKDLM(Oxidation)VIN(N-Glycosylation)R{Hex:6; HexNAc:5; Neu5Ac:2},3672.5273487296095,-1.5922900128501104e-06,10.6655121429,55.3462184236,0,305877038.5,38.9076829777,39.4316916611,39.275463710848,3,2,221,230,sp|Q96KA5|CLP1L_HUMAN Lipid scramblase CLPTM1L OS=Homo sapiens OX=9606 GN=CLPTM1L PE=1 SV=1,Unmodified
TVN(N-Glycosylation)VSVPKKTR{Fuc:1; Hex:6; HexNAc:5},3361.4991695977815,7.325347810763014e-07,-20.7777262552,25.9290534537,0,5751777.25,76.6421193944,76.7046959943,76.704695994282,3,1,88,99,sp|Q96KA5|CLP1L_HUMAN Lipid scramblase CLPTM1L OS=Homo sapiens OX=9606 GN=CLPTM1L PE=1 SV=1,Unmodified
GELN(N-Glycosylation)TSIFSSRPIDK{Fuc:1; Hex:3; HexNAc:4},3107.367818048202,7.643270745119608e-06,13.290808901,17.7408884017,0,129653375.0,40.9473576413,41.1113033758,41.037323759619,3,2,349,364,sp|Q9UHG3|PCYOX_HUMAN Prenylcysteine oxidase 1 OS=Homo sapiens OX=9606 GN=PCYOX1 PE=1 SV=3,Unmodified
VMVLN(N-Glycosylation)R{Fuc:1; Hex:5; HexNAc:5; Neu5Ac:1},2993.239489068406,-3.074998990135045e-06,10.9425853741,34.9341277705,0,52117289.375,23.4444257762,24.2154410945,23.803397459412,3,3,133,139,sp|Q99536|VAT1_HUMAN Synaptic vesicle membrane protein VAT-1 homolog OS=Homo sapiens OX=9606 GN=VAT1 PE=1 SV=2,Unmodified
VSN(N-Glycosylation)YSR{Hex:6; HexNAc:4; Neu5Ac:2},3091.18762683548,-3.869331928052427e-06,14.5826552613,47.3179838839,0,244965435.25,26.0305544085,26.428282943,26.132240711276,3,2,198,204,sp|P15328|FOLR1_HUMAN Folate receptor alpha OS=Homo sapiens OX=9606 GN=FOLR1 PE=1 SV=3,Unmodified
KADLVN(N-Glycosylation)R{Fuc:3; Hex:5; HexNAc:6},3281.39089903,-3.26677392004e-06,0,76.9836817541,0,0,,,,3,1,373,380,sp|Q8WUM4|PDC6I_HUMAN Programmed cell death 6-interacting protein OS=Homo sapiens OX=9606 GN=PDCD6IP PE=1 SV=1,
HFN(N-Glycosylation)KTGQR{Fuc:2; Hex:5; HexNAc:6},3307.38028465,-5.89687681231e-06,0,18.7670230235,0,0,,,,3,1,60,68,sp|P45974|UBP5_HUMAN Ubiquitin carboxyl-terminal hydrolase 5 OS=Homo sapiens OX=9606 GN=USP5 PE=1 SV=2,
LVQLFPN(N-Glycosylation)DTSLK{Fuc:1; Hex:5; HexNAc:5; Neu5Ac:1},3636.575248971838,-1.5063154624777773e-06,11.1726521135,80.0053351031,0,256171235.0,84.8430251108,85.2981709268,85.000568110371,3,1,445,457,sp|Q12797|ASPH_HUMAN Aspartyl/asparaginyl beta-hydroxylase OS=Homo sapiens OX=9606 GN=ASPH PE=1 SV=3,Unmodified
LVQLFPN(N-Glycosylation)DTSLK{Fuc:3; Hex:7; HexNAc:6; Neu5Ac:1},4455.86890768,3.81612889589e-07,0,15.2534352554,0,0,,,,3,1,445,457,sp|Q12797|ASPH_HUMAN Aspartyl/asparaginyl beta-hydroxylase OS=Homo sapiens OX=9606 GN=ASPH PE=1 SV=3,
LVQLFPN(N-Glycosylation)DTSLK{Fuc:4; Hex:6; HexNAc:5},3945.71560834,-3.72654544568e-06,0,10.3468396005,0.0434782608696,0,,,,3,1,445,457,sp|Q12797|ASPH_HUMAN Aspartyl/asparaginyl beta-hydroxylase OS=Homo sapiens OX=9606 GN=ASPH PE=1 SV=3,
KPN(N-Glycosylation)VSPEKR{Hex:6; HexNAc:2},2432.0575613654405,4.611923717462357e-06,11.6868736351,85.0181017971,0,85961678.5,54.2052032775,54.3885181612,54.265927810097,3,1,149,158,sp|Q9HCH5|SYTL2_HUMAN Synaptotagmin-like protein 2 OS=Homo sapiens OX=9606 GN=SYTL2 PE=1 SV=3,Unmodified
ALKN(N-Glycosylation)YTK{Hex:9; HexNAc:5},3310.361435589795,-4.096021044458016e-06,14.6849294954,79.6857639428,0,429302853,40.8582414415,41.2279955413,40.992726324622,3,2,245,252,sp|Q96MW7|TIGD1_HUMAN Tigger transposable element-derived protein 1 OS=Homo sapiens OX=9606 GN=TIGD1 PE=1 SV=1,Unmodified
NEEYN(N-Glycosylation)K{Hex:5; HexNAc:4; Neu5Ac:2},3000.1188532505603,-2.1718401600006066e-06,13.526114427,55.3053915844,0,390938931.75,25.2589033948,26.0457511451,25.664596158886,3,2,51,57,sp|P19652|A1AG2_HUMAN Alpha-1-acid glycoprotein 2 OS=Homo sapiens OX=9606 GN=ORM2 PE=1 SV=2,Unmodified
LN(N-Glycosylation)LTGAVR{Hex:6; HexNAc:8},3439.4561548865204,-1.986718176646749e-06,14.8079696454,62.4894545923,0,174149514.5,25.8379814412,25.9420757081,25.896744841957,3;4,2,982,990,sp|Q5DID0|UROL1_HUMAN Uromodulin-like 1 OS=Homo sapiens OX=9606 GN=UMODL1 PE=2 SV=2,Unmodified
LKN(N-Glycosylation)ISPK{Fuc:1; Hex:6; HexNAc:6; Neu5Ac:1},3426.437316919544,1.6116956578530147e-06,12.2639299361,90.3863218519,0,308882250.0,81.7090287433,82.2728395448,81.910714577262,3,2,615,622,sp|Q8NDH2|CC168_HUMAN Leucine-rich repeat transmembrane protein CCDC168 OS=Homo sapiens OX=9606 GN=CCDC168 PE=2 SV=3,Unmodified
AN(N-Glycosylation)QSLKHLR{Fuc:1; Hex:9; HexNAc:5},3685.5474833965923,-3.5206612452714456e-06,6.42935291014,61.8852170449,0,27319196.75,78.3935747928,78.7068810767,78.393574792767,3,1,786,795,"sp|Q8WX94|NALP7_HUMAN NACHT, LRR and PYD domains-containing protein 7 OS=Homo sapiens OX=9606 GN=NLRP7 PE=1 SV=1",Unmodified
M(Oxidation)SLQLYLVDN(N-Glycosylation)R{Hex:5; HexNAc:4},2989.276946381283,-1.2888866011206698e-06,13.5761920691,24.2105235419,0,186471036.25,76.7823735263,77.0773322449,76.937399008497,3,4,452,463,sp|P54646|AAPK2_HUMAN 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Homo sapiens OX=9606 GN=PRKAA2 PE=1 SV=2,Unmodified
M(Oxidation)SLQLYLVDN(N-Glycosylation)R{Hex:7; HexNAc:6},3719.56118389,-6.37130839326e-06,0,11.065090566,0.0229885057471,0,,,,3,1,452,463,sp|P54646|AAPK2_HUMAN 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Homo sapiens OX=9606 GN=PRKAA2 PE=1 SV=2,
AN(N-Glycosylation)KTPIRM(Oxidation)R{Fuc:2; Hex:8; HexNAc:8; Neu5Ac:1},4605.88100887,-9.79200965377e-07,0,20.2102572385,0,0,,,,3,1,21151,21160,sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4,
TC(Carbamidomethyl)ILEILN(N-Glycosylation)STKR{Fuc:1; Hex:6; HexNAc:4; Neu5Ac:1},3668.58612154,-3.24821610145e-06,0,13.4505278211,0,0,,,,3,1,6966,6978,sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4,
KNGIN(N-Glycosylation)VTPSQR{Fuc:1; Hex:6; HexNAc:5; Neu5Ac:1},3637.52627485,-4.57177357426e-07,0,11.7705162992,0.0229885057471,0,,,,3,1,8829,8840,sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4,
VVGPIRFTN(N-Glycosylation)ITGEK{Fuc:5; Hex:8; HexNAc:7},4978.12239465,3.85988259702e-07,0,10.311411503,0.0489130434783,0,,,,4,1,28981,28995,sp|Q8WZ42|TITIN_HUMAN Titin OS=Homo sapiens OX=9606 GN=TTN PE=1 SV=4,
KGN(N-Glycosylation)YSER{Fuc:1; Hex:4; HexNAc:5},2662.0735435310003,5.640142036392339e-07,10.0116848822,41.5158415885,0,29517577.6875,24.3511514928,24.6238145775,24.531738510354,3,2,36,43,sp|P20671|H2A1D_HUMAN Histone H2A type 1-D OS=Homo sapiens OX=9606 GN=H2AC7 PE=1 SV=2,Unmodified
